Advertisement

Topic - David Ridley

Related Stories

A selection of eye drops line a shelf at a pharmacy in Los Angeles on Tuesday, Dec. 12, 2023. Repeated recalls of eyedrops are drawing new attention to the limited powers U.S. regulators have to oversee medical products made overseas. Unlike prescription drugs, eyedrops and other over-the-counter products don't get preliminary review by the Food and Drug Administration. (AP Photo/Richard Vogel)

After recalls and infections, experts say safer eyedrops will require new FDA regulations

By Matthew Perrone - Associated Press

A selection of eye drops line a shelf at a pharmacy in Los Angeles on Tuesday, Dec. 12, 2023. A series of recalls involving over-the-counter drops is drawing new attention to just how little U.S. officials know about the conditions at manufacturing plants on the other side of the world and the limited tools they have to force products off the market when there's a problem. (AP Photo/Richard Vogel)

After recalls and infections, experts say safer eyedrops will require new FDA powers

By Matthew Perrone - Associated Press